Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 243

Similar articles for PubMed (Select 17608261)

1.

Resolution of nonalcoholic steatohepatits after gastric bypass surgery.

Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA.

Obes Surg. 2007 Apr;17(4):486-92.

PMID:
17608261
2.

Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.

Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.

Obes Surg. 2006 Dec;16(12):1584-93.

PMID:
17217634
3.

Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease.

Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH.

Obes Res. 2005 Jul;13(7):1180-6.

PMID:
16076987
4.

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery.

Barker KB, Palekar NA, Bowers SP, Goldberg JE, Pulcini JP, Harrison SA.

Am J Gastroenterol. 2006 Feb;101(2):368-73.

PMID:
16454845
5.

Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Arun J, Jhala N, Lazenby AJ, Clements R, Abrams GA.

Obes Surg. 2007 Feb;17(2):155-61.

PMID:
17476865
6.

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ.

J Gastroenterol Hepatol. 2007 Apr;22(4):510-4.

PMID:
17376042
7.

Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity.

de Almeida SR, Rocha PR, Sanches MD, Leite VH, da Silva RA, Diniz MT, Diniz Mde F, Rocha AL.

Obes Surg. 2006 Mar;16(3):270-8.

PMID:
16545157
8.

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.

Obes Surg. 2008 Jul;18(7):847-53. doi: 10.1007/s11695-007-9355-0. Epub 2008 May 6.

PMID:
18459024
9.

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.

Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32.

PMID:
16469684
10.

Nonalcoholic fatty liver disease treated by gastroplasty.

Jaskiewicz K, Raczynska S, Rzepko R, Sledziński Z.

Dig Dis Sci. 2006 Jan;51(1):21-6.

PMID:
16416204
11.

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

Dixon JB, Bhathal PS, Hughes NR, O'Brien PE.

Hepatology. 2004 Jun;39(6):1647-54.

PMID:
15185306
12.

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. Epub 2007 Aug 16.

PMID:
17702661
14.

Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings.

Oliveira CP, Faintuch J, Rascovski A, Furuya CK Jr, Bastos Mdo S, Matsuda M, Della Nina BI, Yahnosi K, Abdala DS, Vezozzo DC, Alves VA, Zilberstein B, Garrido AB Jr, Halpern A, Carrilho FJ, Gama-Rodrigues JJ.

Obes Surg. 2005 Apr;15(4):502-5.

PMID:
15946429
15.

Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.

Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR.

Arch Surg. 2003 Nov;138(11):1240-4.

PMID:
14609874
16.

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.

Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F.

Gastroenterology. 2009 Aug;137(2):532-40. doi: 10.1053/j.gastro.2009.04.052. Epub 2009 May 4.

PMID:
19409898
17.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
18.

Obesity surgery results depending on technique performed: long-term outcome.

Gracia JA, Martínez M, Elia M, Aguilella V, Royo P, Jiménez A, Bielsa MA, Arribas D.

Obes Surg. 2009 Apr;19(4):432-8. doi: 10.1007/s11695-008-9762-x. Epub 2008 Nov 12.

PMID:
19002740
19.

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.

Abrams GA, Kunde SS, Lazenby AJ, Clements RH.

Hepatology. 2004 Aug;40(2):475-83.

PMID:
15368453
20.

Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?

Helling TS, Helzberg JH, Nachnani JS, Gurram K.

Surg Obes Relat Dis. 2008 Sep-Oct;4(5):612-7. doi: 10.1016/j.soard.2007.11.007. Epub 2008 Jan 28.

PMID:
18226970
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk